Galectin Therapeutics (GALT) Stock Chart & Stock Price History $2.15 -0.02 (-0.69%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$2.15 0.00 (-0.23%) As of 07/3/2025 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galectin Therapeutics Stock Price Performance The Galectin Therapeutics (GALT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 0.23%, with a year-to-date return of 67.05%. In the past month, the stock has increased 68.36%, reflecting recent market activity. As of the latest close, Galectin Therapeutics traded at $2.16 with a market cap of $136.39 million and volume of 239,497 shares. Five years ago, the stock traded at $3.11, representing a 30.71% decrease over that period. At the time, it had a market cap of $178.35 million and a volume of 177,300 shares. Receive GALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.51%1 Month Performance+68.36%3 Month Performance+63.26%Year-To-Date Performance+67.05%1 Year Performance+0.23%5 Year Performance-30.71% GALT Stock Chart for Friday, July, 4, 2025 GALT Chart by TradingView Galectin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$2.16$2.16$2.24$2.13239,497 shs$136.39 million07/03/2025$2.17$2.16-0.69%$2.24$2.13239,497 shs$136.39 million07/02/2025$2.22$2.17-2.25%$2.26$2.08271,287 shs$137.34 million07/01/2025$2.11$2.22+5.21%$2.27$2.10446,212 shs$140.50 million06/30/2025$2.33$2.11-9.44%$2.59$2.11455,660 shs$133.54 million06/27/2025$2.35$2.33-0.85%$2.63$2.301.95 million shs$147.47 million06/26/2025$2.51$2.35-6.37%$2.66$2.34497,877 shs$148.74 million06/25/2025$2.42$2.51+3.72%$2.63$2.43292,350 shs$158.86 million06/24/2025$2.48$2.42-2.42%$2.64$2.21543,423 shs$153.16 million06/23/2025$2.42$2.48+2.48%$2.80$2.25975,728 shs$156.96 million Get the Latest News and Ratings for GALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$3.29$2.42-26.44%$3.90$1.854.32 million shs$153.16 million06/19/2025$3.29$3.29$3.30$2.315.37 million shs$208.22 million06/18/2025$2.39$3.29+37.66%$3.30$2.315.37 million shs$208.22 million06/17/2025$1.49$2.39+60.40%$2.79$1.5411.56 million shs$151.27 million06/16/2025$1.37$1.49+8.76%$1.69$1.38627,591 shs$94.31 million06/13/2025$1.34$1.37+2.24%$1.38$1.33187,662 shs$86.71 million06/12/2025$1.32$1.34+1.52%$1.38$1.32100,466 shs$84.81 million06/11/2025$1.34$1.32-1.49%$1.39$1.3194,225 shs$83.55 million06/10/2025$1.32$1.34+1.52%$1.39$1.30176,640 shs$84.81 million06/09/2025$1.32$1.32$1.35$1.28165,620 shs$83.55 million06/06/2025$1.30$1.32+1.54%$1.36$1.29242,973 shs$83.55 million06/05/2025$1.28$1.30+1.56%$1.32$1.27185,892 shs$82.28 million06/04/2025$1.29$1.28-0.78%$1.33$1.2893,815 shs$81.01 million06/03/2025$1.29$1.29$1.33$1.28130,720 shs$81.65 million Related Companies CDXC Stock Price Chart XNCR Stock Price Chart KALV Stock Price Chart EOLS Stock Price Chart SANA Stock Price Chart UPB Stock Price Chart SAGE Stock Price Chart ALT Stock Price Chart TNGX Stock Price Chart KROS Stock Price Chart Receive GALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GALT) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galectin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
